胺碘酮治疗急性心肌梗死伴心房颤动的临床疗效

朱玉江，王西辉

（西安医学院第二附属医院，陕西 西安，710038）

浏览次数：79次 下载次数：338次

摘要：

目的 探究急性心肌梗死伴心房颤动患者给予胺碘酮治疗的临床效果。方法 选择2014年6月至2016年8月的我院收治的86例急性心肌梗死并发心房颤动患者，随机分为观察组和对照组，各43 例。观察组采用胺碘酮，对照组采用美托洛尔，对比 两组患者的治疗效果、不良反应情况、生活质量评分及MUIS 评分。结果 与对照组相比，观察组患者的治疗效果良好，生活质量 各项评分明显更高（P<0.05）；观察组不良反应发生率仅为4.65%，MUIS 评分为（36.82±2.71）分，分别低于对照组的18.60%与（52.16±3.38）分，差异有统计学意义（P<0.05）。结论 胺碘酮治疗急性心肌梗死并发心房颤动患者的临床效果非常显著。

关键词：急性心肌梗死；胺碘酮；心房颤动

中图分类号：R541.7文献标志码：A文章编号：2096-1413(2017)34-0026-02

Clinical effect of amiodarone in the treatment of acute myocardial infarction complicated with atrial fibrillation
ZHU Yu-jiang, WANG Xi-hui
(the Second Affiliated Hospital of Xi``an Medical University, Xi``an 710038, China)

ABSTRACT: Objective To explore the clinical effect of amiodarone in patients with acute myocardial infarction complicated with atrial fibrillation. Methods A total of 86 patients with acute myocardial infarction complicated with atrial fibrillation from June 2014 to August 2016 were selected and randomly divided into observation group and control group, with 43 cases in each group. The observation group received amiodarone, and the control group received metoprolol. The treatment effects, adverse reactions, the scores of life quality and the scores of MUIS were compared between the two groups. Results Compared with the control group, the treatment effect of the observation group was better, and the quality of life scores were significantly higher (P<0.05); the adverse reaction rate was only 4.65%, the MUIS score was (36.82± 2.71) in the observation group, which were respectively lower than 18.60% and （52.16 ±3.38）in the control group, the differences were statistically significant (P<0.05). Conclusion The clinical effect of amiodarone in patients with acute myocardial infarction complicated with atrial fibrillation is very significant.
KEYWORDS: acute myocardial infarction; amiodarone; atrial fibrillation

参考文献：
[1] 黄月华,张黔桓.急性心肌梗死后室性心律失常应用胺碘酮治疗的临床观察[J].现代诊断与治疗,2016,27(12):2236-2237.
[2] 乔崇.胺碘酮用于急性心肌梗死后室性心律失常的治疗分析[J].临床医药文献杂志:电子版,2016,3(25):5089.
[3] BEPPU K,DOI T,HOSOKAWA A.et al.Full neurological recovery, cerebral performance category (CPC) 1, after 65-minute cardiac arrest using percutaneous cardiopulmonary system and therapeutic hypothermia [J].Int J Cardiol,2013,168(5):4893-4895.
[4] LI T,WEI X,WATKINS AC,et al.Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction[J].J Surg Res,2013,185(1):152-158.
[5] 刘莉娟,袁清茹,赵明中,等.胺碘酮联合丹参酮域A 磺酸钠治疗急 性心肌梗死并发房颤的效果[J].中国临床药理学杂志,2016,32(9):781-782.
[6] TURAGAM MK,DOWNEY F,KRESS D,et al.Pharmacological strategies for prevention of postoperative atrial fibrillation[J].Expert Rev Clin Pharmacol,2015,8(2):233-250.
[7] MORVAY N,BACZK I,SZTOJKOVIVANOV A,et al.Long -term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats[J].Can J Physiol Pharmacol,2015,93(9):773-777.
[8] 严华芳,黄秀英,蔡金芳.普罗帕酮联合胺碘酮治疗老年急性心肌梗死合并AF 的临床分析[J].中国处方药,2015,13(6):12-13.
[9] 孔令军,谷守星,奚舜毅,等.丹参酮域A 磺酸钠注射液联合盐酸胺碘酮注射液治疗急性心肌梗死并发心房颤动48 例疗效观察[J].河北 中医,2013,35(1):96-97.